Navigation Links
Dr. Susan Froshauer to join Connecticut bioscience team at CURE
Date:2/12/2013

HARTFORD, Conn., Feb. 12, 2013 /PRNewswire/ -- Peter R. Farina , Ph.D. and David W. Keiser , the two co-chairs of CURE (Connecticut United for Research Excellence), the state bioscience organization, today released the following statement about organizational changes at CURE.

After ten years at the helm, Paul Pescatello , the current President and CEO of CURE, has decided to step back from that role so that he can dedicate some additional time to private business ventures and other non-life sciences policy issues. Paul has made great strides for CURE and so we are pleased to report that he has agreed to continue to coordinate our government relations efforts as Chair of the CURE BioScience Growth Council and as a CURE Board and Executive Committee member. This arrangement will allow Paul to bring even greater focus and depth to CURE's life sciences advocacy.

The state has recently increased its investment in the life sciences and in entrepreneurship. For example, it has invited The Jackson Laboratory to develop a genomic medicine facility in Farmington and created Connecticut's Innovation Ecosystem, a public-private partnership, with hubs in Hartford, New Haven, Stamford and Storrs, to support high-value technology-based start-up and stage 2 companies. Furthermore, Governor Malloy has proposed a new $200 million Bioscience Innovation Act and announced a $1.5 million investment in UConn to support

SOURCE CURE (Connecticut United for Research Excellence)
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Connecticut Radiology Group Leverages MedInformatix RIS to Achieve Stage 1 Meaningful Use Objectives
2. Medbox, Inc. Rides a Wave of Local Media Support in Connecticut
3. Lilly Applauds Law Enforcement Officials for their Successful Investigation and Recovery of Pharmaceuticals Stolen from Connecticut Distribution Center
4. Sigma-Aldrich Corporations Sigma Life Science Business to Distribute Worldwide Olink Biosciences Protein Interaction Analysis Technology
5. Sangamo BioSciences Reports Fourth Quarter And Full Year 2012 Financial Results
6. Neurocrine Biosciences To Present At The Leerink Swann Global Healthcare Conference 2013
7. Neurocrine Biosciences Announces Conference Call And Webcast To Present Fourth Quarter And Year-End 2012 Financial Results
8. Amarantus BioScience Secures an Additional $1.4 Million in Financing Commitments
9. Neurocrine Biosciences Announces Additional European And United States Patents Issued On Proprietary VMAT2 Inhibitor
10. Congresswoman Barbara Lee Visits Tethys Bioscience
11. IntelliCell BioSciences Receives Notice of Allowance for its US Patent for "Ultrasonic Cavitation of Adipose Tissue to Produce Stromal Vascular Fraction Regenerative Cells"
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2014)... 21, 2014  Heated dialogue in recent months about ... cancer treatments to Gilead,s new hepatitis C drug Harvoni® ... world questioning what it means to put a price ... And while drug pricing is one of the ... both a general business and ethical standpoint – it ...
(Date:11/21/2014)... N.J. , Nov. 21, 2014  PTC Therapeutics, Inc. ... the 2014 Legend of Technology Award for Vision, Innovation, and ... Ph.D., Chief Executive Officer. This award recognizes an individual who ... New Jersey for several decades. ... Technology Award," stated Stuart Peltz , Ph.D., CEO of ...
(Date:11/21/2014)... , Nov. 21, 2014 ... European Medicines Agency (EMA) has granted Orphan ... lead product candidate, for the treatment of ... rare, severely disabling genetic disease characterized by ... (flare-ups) and new abnormal bone formation. This ...
Breaking Medicine Technology:"The Price of Global Health" Tackles Worldwide Drug-Pricing Debate 2"The Price of Global Health" Tackles Worldwide Drug-Pricing Debate 3"The Price of Global Health" Tackles Worldwide Drug-Pricing Debate 4"The Price of Global Health" Tackles Worldwide Drug-Pricing Debate 5PTC Therapeutics Announces CEO, Dr. Stuart Peltz Recipient of The New Jersey Technology Council's 2014 Legend of Technology Award 2PTC Therapeutics Announces CEO, Dr. Stuart Peltz Recipient of The New Jersey Technology Council's 2014 Legend of Technology Award 3Clementia Pharmaceuticals Receives EMA Orphan Medicinal Product Designation for Palovarotene for the Treatment of Fibrodysplasia Ossificans Progressiva 2Clementia Pharmaceuticals Receives EMA Orphan Medicinal Product Designation for Palovarotene for the Treatment of Fibrodysplasia Ossificans Progressiva 3
... Reportlinker.com announces that a new ... its catalogue: Women,s ... to 2016 - High Unmet Need ... Drugs in the Menopause and Osteoporosis ...
... ST. LOUIS, Oct. 6, 2011 Express Scripts, Inc. ... guidance with respect to anticipated future financial results.  This ... and expectations, and, as stated in the Company,s various ... those originally projected or suggested in such guidance for ...
Cached Medicine Technology:Women's Health Therapeutics, Analysis and Market Forecasts to 2016 - High Unmet Need will Drive the Uptake of Novel Drugs in the Menopause and Osteoporosis Markets 2Women's Health Therapeutics, Analysis and Market Forecasts to 2016 - High Unmet Need will Drive the Uptake of Novel Drugs in the Menopause and Osteoporosis Markets 3Women's Health Therapeutics, Analysis and Market Forecasts to 2016 - High Unmet Need will Drive the Uptake of Novel Drugs in the Menopause and Osteoporosis Markets 4Women's Health Therapeutics, Analysis and Market Forecasts to 2016 - High Unmet Need will Drive the Uptake of Novel Drugs in the Menopause and Osteoporosis Markets 5Women's Health Therapeutics, Analysis and Market Forecasts to 2016 - High Unmet Need will Drive the Uptake of Novel Drugs in the Menopause and Osteoporosis Markets 6Women's Health Therapeutics, Analysis and Market Forecasts to 2016 - High Unmet Need will Drive the Uptake of Novel Drugs in the Menopause and Osteoporosis Markets 7Women's Health Therapeutics, Analysis and Market Forecasts to 2016 - High Unmet Need will Drive the Uptake of Novel Drugs in the Menopause and Osteoporosis Markets 8Women's Health Therapeutics, Analysis and Market Forecasts to 2016 - High Unmet Need will Drive the Uptake of Novel Drugs in the Menopause and Osteoporosis Markets 9Women's Health Therapeutics, Analysis and Market Forecasts to 2016 - High Unmet Need will Drive the Uptake of Novel Drugs in the Menopause and Osteoporosis Markets 10Women's Health Therapeutics, Analysis and Market Forecasts to 2016 - High Unmet Need will Drive the Uptake of Novel Drugs in the Menopause and Osteoporosis Markets 11Women's Health Therapeutics, Analysis and Market Forecasts to 2016 - High Unmet Need will Drive the Uptake of Novel Drugs in the Menopause and Osteoporosis Markets 12Women's Health Therapeutics, Analysis and Market Forecasts to 2016 - High Unmet Need will Drive the Uptake of Novel Drugs in the Menopause and Osteoporosis Markets 13Express Scripts Announces Revised 2011 Financial Guidance 2Express Scripts Announces Revised 2011 Financial Guidance 3Express Scripts Announces Revised 2011 Financial Guidance 4Express Scripts Announces Revised 2011 Financial Guidance 5Express Scripts Announces Revised 2011 Financial Guidance 6Express Scripts Announces Revised 2011 Financial Guidance 7Express Scripts Announces Revised 2011 Financial Guidance 8Express Scripts Announces Revised 2011 Financial Guidance 9Express Scripts Announces Revised 2011 Financial Guidance 10
(Date:11/21/2014)... Richard Wolfe, co-founder and CEO of ... benefits administration strategies during the Game Changer session ... This Game Changer breakout session enables emerging providers ... solutions and best practices to top HR leaders. ... exchange between health and welfare benefits partners, HR ...
(Date:11/21/2014)... 2014 Big Bud Farms announced today ... of Innovations with Ed Begley Jr., airing via Discovery ... , Big Bud Farms, growers of legal medical marijuana, ... utilization of medical marijuana. , This segment of Innovations ... variety of products for medicating. Viewers will learn about ...
(Date:11/21/2014)... In summer, when it’s hot out, ... perspire and rarely feel thirsty. As a result, less ... glasses of fresh water a day recommended for health ... Sharon Kleyne. Winter weather is often more dehydrating than ... important.     , The syndicated Sharon Kleyne ...
(Date:11/21/2014)... Recently, TideStore.com, a leading online store offering many chic ... TideStore Thanksgiving Sales . According to the company’s ... with big discounts. The special offer is valid during ... 10% discount with this coupon code: thanks. , Visitors ... to win free gifts. TideStore.com has done much market ...
(Date:11/21/2014)... Beach, FL (PRWEB) November 21, 2014 ... report issued on June 11th, 2014, the inflating ... can rupture when the airbag inflates. The force of ... metal shrapnel, and the metal shards may pierce the ... the vehicle’s cabin. , According to a Bloomberg ...
Breaking Medicine News(10 mins):Health News:Empyrean Benefit Solutions CEO Sharing Latest Benefits Administration Strategies with Houston HR Leaders 2Health News:Empyrean Benefit Solutions CEO Sharing Latest Benefits Administration Strategies with Houston HR Leaders 3Health News:Big Bud Farms to be Featured in Upcoming Episode of Innovations with Ed Begley Jr. 2Health News:Our Bodies Need Eight Glasses of Water a Day Even in Winter Reports Fresh Water Advocate 2Health News:Our Bodies Need Eight Glasses of Water a Day Even in Winter Reports Fresh Water Advocate 3Health News:Thanksgiving Sales from TideStore.com 2Health News:Takata Airbag Recall Class Action Lawsuit Resource Released by Florida Injury Attorney 2Health News:Takata Airbag Recall Class Action Lawsuit Resource Released by Florida Injury Attorney 3
... published the first comprehensive review of evidence on pneumococcal ... available in the on-line edition of the journal Lancet ... risk of pneumococcal infection by up to 40 fold, ... the PCV, and that the vaccine can protect HIV-infected ...
... San Diego have developed a novel computer technique to ... study, reported November 30 in PLoS Computational Biology relates ... Receptor Modulators (SERMs), which includes tamoxifen, the most prescribed ... side effects account for one-third of all drug development ...
... President of International Operations, MONROVIA, Calif., Nov. ... a leading developer, manufacturer and marketer of,minimally invasive ... has been named President and Chief Executive Officer. ... the annual shareholder,s,meeting in May 2007, replaces David ...
... Nov. 28 Novant Health(R) today announced ... leader,in developing and manufacturing medical devices for ... implement the Cardiocom System in its,Presbyterian Heart ... Hospital is one of the largest healthcare ...
... ASHBURN, Va., Nov. 28 Innocoll, Inc. announced ... that pursuant to,Rule 51(4) EPC, the European Patent ... applications which are both based on its proprietary,CollaRx ... Treatment of,Wounds" and Patent No. 1265648 entitled "Novel ...
... Corporation,("Sosei"; TSE Mothers Index: 4565), a biopharmaceutical company, ... UK Medicines and,Healthcare products Regulatory Agency (MHRA) for ... sublingual spray (AD 923), an opioid,analgesic for the ... trial authorisation (CTA) covers two multi-centre pivotal,Phase III ...
Cached Medicine News:Health News:Pneumococcal conjugate vaccines can improve the lives of HIV-infected children 2Health News:Barry G. Caldwell Named Chief Executive Officer of STAAR Surgical 2Health News:Barry G. Caldwell Named Chief Executive Officer of STAAR Surgical 3Health News:Barry G. Caldwell Named Chief Executive Officer of STAAR Surgical 4Health News:Barry G. Caldwell Named Chief Executive Officer of STAAR Surgical 5Health News:Barry G. Caldwell Named Chief Executive Officer of STAAR Surgical 6Health News:Novant Health(R) Selects Cardiocom(R) to Provide Telemonitoring for Presbyterian Hospital Heart Failure Program 2Health News:Innocoll Receives 'Intends to Grant' Notices from the European Patent Office for Two European Patent Applications Related to Novel Wound Healing, Biosurgery and Drug Delivery Applications of its CollaRx(R) Technology 2Health News:Innocoll Receives 'Intends to Grant' Notices from the European Patent Office for Two European Patent Applications Related to Novel Wound Healing, Biosurgery and Drug Delivery Applications of its CollaRx(R) Technology 3Health News:Innocoll Receives 'Intends to Grant' Notices from the European Patent Office for Two European Patent Applications Related to Novel Wound Healing, Biosurgery and Drug Delivery Applications of its CollaRx(R) Technology 4Health News:Sosei Announces Approval to Start AD 923 Phase III Studies in Europe 2
The Freedom Clear® LS Long Seal is a 100% latex-free, self-adhering, one piece catheter with an ultra-thin sheath for everyday wear. Its long seal provides added security....
The UltraFlex® all silicone self-adhering male external catheter is 100% latex-free and eliminates the risk of latex-related skin irritations. This breathable catheter promotes healthy skin and i...
Used as a percutaneous entry needle to introduce wire guides. The coaxial design reduces potential A.V. malformations. Supplied sterile in peel-open packages. Intended for one-time use....
... Used for stone manipulation ... tract. Enhanced wire strength permits ... ureter more readily than standard ... facilitates easy, ergonomic one-handed operation. ...
Medicine Products: